High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial
Autor: | Jolicoeur, M., Derashodian, T., Nguyen-Huynh, T.V., de Castro Hellmann, E., Mondat, M., Nachabe, M., Antebi, E., Wakil, G., Héliou, R. |
---|---|
Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 September 2019 105(1) Supplement:E284-E284 |
Databáze: | ScienceDirect |
Externí odkaz: |